CAT No: CP25167
CAS No:112883-42-8
Synonyms/Alias:112883-42-8;Fmoc-N-Me-Nle-OH;Fmoc-N-methyl-L-norleucine;(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)hexanoicacid;Fmoc-Nalpha-methyl-L-norleucine;AmbotzFAA6460;L-Norleucine,N-[(9H-fluoren-9-ylmethoxy)carbonyl]-N-methyl-;SCHEMBL119776;TMA044;CTK4A8010;MolPort-006-705-971;ZINC2560005;CF-828;MFCD00235878;AKOS015837161;CS11418;RTR-062402;AJ-40413;AK-85719;SC-89920;KB-300453;TR-062402;FT-0689530;N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-N-methyl-L-norleucine;(2S)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl](methyl)amino}hexanoicacid
Chemical Name:N-alpha-(9-Fluorenylmethyloxycarbonyl)-N-alpha-methyl-L-norleucine
1. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
2. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
3. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
4. High fat diet and GLP-1 drugs induce pancreatic injury in mice
5. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.